From enlightening talks to networking opportunities, here's where you need to be in April. Getty Images

Happy Q2, everyone. With 2019 already a quarter of the way through, it's a bit overwhelming to prioritize what networking and thought talks to attend. We've rounded up a list of over 10 (and growing) events for you to consider adding to your calendar.

If you know of innovation-focused events for this month or next, email me at natalie@innovationmap.com with the details and subscribe to our daily newsletter that sends fresh stories straight to your inboxes every morning.

April 4 — FIRMSPACE Houston Grand Opening Celebration

A national high-end workspace brand has opened its latest location in Houston. Check out the space and network with potential coworkers.

Details: The event is from 7 to 10 pm on Thursday, April 4, at FIRMSPACE Houston (2200 Post Oak Boulevard). Learn more.

April 4 — Accelerator Info Session and Panel

Join the Social Enterprise Alliance for an info session on BBVA Momentum's accelerator program followed by a panel discussion led by Grace Rodriguez, CEO of Impact Hub Houston.

Details: The event is from 11:30 am to 1 pm on Thursday, April 4, at Station Houston (1301 Fannin, suite 2440). Learn more.

April 4-6 — Rice Business Plan Competition

This weekend, 42 teams will be competing for over $1.5 million in awards at the 19th annual Rice Business Plan Competition. Learn more about the awards and teams here.

Details: The three-day challenge takes place in a few different buildings on Rice University Campus. Learn more.

April 5 — ChIPs Texas' Houston Innovation Ecosystem

Gina Luna of Houston Exponential and Tom Luby of the TMC Innovation Institute will take the stage for a panel moderated by Payal Patel of Station Houston. It's the first ChIPs event in Houston. ChIPs is a nonprofit organization that advances and connects women in technology, law, and policy.

Details: The event is from 11:30 am to 1:30 pm on Friday, April 5, at TMC Innovation Institute (2450 Holcombe Blvd, Suite X). Learn more.

April 10 — MassChallenge Texas' Houston Launch Party

In case you missed it, MassChallenge Texas has a new Houston program and it's officially launching this month. Network with the international program, potential applicants, and other members of the Houston innovation ecosystem.

Details: The event is from 6 to 8 pm on Wednesday, April 10, at Four Seasons Houston (1300 Lamar St.). Learn more.

April 11 — 2019 Future of Leadership Luncheon

The annual event honors leadership and celebrates the important role of philanthropy in the Houston community. Tickets start at $250 for the luncheon that features a conversation between Darren Walker, president of the Ford Foundation, and Laura Arnold, co-chair of Arnold Ventures, on the future of philanthropy.

Details: The event is from noon to 1:30 pm on Thursday, April 11, at the Hilton Americas (1600 Lamar Street). Learn more here.

April 11 — Startup Pains: What I Wish I Knew

This monthly series hosted by the University of Houston lets you learn from someone else's mistakes and successes. This month's speaker is Jason Eriksen, Ph.D.UH associate professor of pharmacy, and founder of Alzeca Biosciences and Teomics LLC.

Details: The event is from 4 to 5 pm on Thursday, April 11, at the UH Technology Bridge (Innovation Center, building 4, floor 2, 5000 Gulf Fwy). Learn more here.Learn more here.

April 11 — B2B Startup Pitch Party

Cannon Ventures is hosting another night of pitches. This event is focused on all things B2B and will feature some B2B startups looking for early stage funding in Houston.

Details: The event is from 6:30 to 9 pm on Thursday, April 11, at The Cannon (1336 Brittmoore Road). Learn more.

April 12 — The Agile Shift Conference

Join industry professionals to network and talk the unification of Agile and DevOps to build and deliver better teams and software.

Details: The event is from 8 am to 5 pm on Friday, April 12, at the Hyatt Regency Houston (1200 Louisiana St.). Learn more.

April 18 — Lemonade Day at Station Houston

Join Station Houston for what is likely going to be the cutest pitch competition you'll ever see. Ten teams made up of future entrepreneurs will pitch their ideas for a lemonade stand.

Details: The event is from 5:30 to 7:30 pm on Thursday, April 18, at Station Houston (1301 Fannin Street, suite 2440). Learn more.

April 18 — Rice Alumni | Entrepreneurs & Innovators, Houston Launch

A Rice University organization has a new name, and they are ready to celebrate it. Meet the new Rice Alumni | Entrepreneurs & Innovators network, or RA|EI, and discuss what you want out of the organization.

Details: The event is from 5:30 to 7:30 pm on Thursday, April 18, at Pitch 25 (2120 Walker Street). Learn more.

April 23 — Houston Female Founder Roundtable: How to Get Ahead in Entrepreneurship with Alice

A panel of entrepreneurial women will share their stories, challenges, successes, and tips.

Details: The event is from 11 am to 1 pm on Tuesday, April 23, at The Cannon (1336 Brittmoore Rd). Learn more.

April 25 — EO Talks Houston

Think TED Talks but from Houston entrepreneurs. The goal is to share success stories and inspire other entrepreneurs in town.

Details: The event is from 7:30 to 10:30 am on Thursday, April 25, at Houston Baptist University, Linda & Archie Dunham Theater (7502 Fondren Road). Learn more.

April 25 — 7th Annual City of Houston Investor Conference

The City of Houston is gathering professionals to talk money for a full day of presentations by local government CFOs and an update on the region's economy.

Details: The event is from 8 am to 5 pm on Thursday, April 25, at Hilton Americas-Houston (1600 Lamar Street). Learn more.

April 25 — Enterprise XR: How AR/VR is Preparing Modern Workers

Immersive technology is shifting the paradigm of corporate training, and you and your company need to learn about it. The event has a keynote speaker and networking before and after.

Details: The event is from 6:30 to 8 pm on Thursday, April 25, at Station Houston (1301 Fannin St., suite 2440). Learn more.

April 26 — Data Science and You: Ethics in Data Science

Visiting professor Lawrence Hunter, director of the Computational Bioscience Program and of the Center for Computational Pharmacology at the University of Colorado School of Medicine, talks advances in data science and what you need to know.

Details: The event is from 3 to 5 pm on Friday, April 26, at the University of Houston Student Center (4455 University Drive).Learn more here.

April 26 — SPE Pitch Perfect

Join the Society of Professional Engineers' GCS Innovate! Committee for an event that will help you perfect your business plan.

Details: The event is from 9 am to 2 pm on Friday, April 26, at the Newpark Drilling Fluids (21920 Merchants Way). Learn more here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Baylor College of Medicine launches VC fund to invest in biotech startups

fresh funding

Houston’s Baylor College of Medicine just unveiled a new venture capital fund that backs early-stage biotech startups—and it’s already made its first investment.

BCM Legacy Fund I, funded by philanthropies, invested an undisclosed amount in Houston biotech startup Nemea Therapeutics. Nemea, a spinout of the Baylor College of Medicine and Germany’s Lead Discovery Center, is developing an oral drug to treat metastatic triple-negative breast cancer that no longer responds to currently available therapies.

This type of aggressive cancer spreads from the breast to other areas of the body, such as the bones, liver, lungs or brain. Roughly 38,000 to 57,000 Americans are diagnosed each year with metastatic triple-negative breast cancer. One study showed about half of patients survive past the one-year mark following diagnosis and about one-third survive two years.

“Baylor College of Medicine’s laboratories produce discoveries with the potential to change patients’ lives, and too many of them stall where academic funding ends and private investment has not yet begun,” Dr. Jakub Tolar, president, CEO and executive dean of the Baylor College of Medicine, said in a press release. “The BCM Legacy Fund fills that gap, giving our scientists a path to advance their discoveries to patients.”

The National Institutes of Health awards more than $36 billion per year for biomedical research in the U.S., Baylor said. But some biomedical discoveries “never leave the starting line because they don’t yet fit the economics of venture capital,” the college said.

“The forefront of a new model”

The BCM Legacy Fund aggregates philanthropic capital from private foundations and donor-advised funds. It then invests in startups so they can move beyond that starting line and into later-stage investment rounds. The Greater Houston Community Foundation is the fund’s philanthropic partner.

“It’s exciting to be on the forefront of a new model for philanthropic capital,” said Houston entrepreneur and investor Burton Hanson, managing partner of the fund.

“Not only do we hope to solve a real problem by advancing these therapies to the patients who need them most, but we also hope this model will inspire others in the city and beyond toward philanthropic creativity and a posture of ‘I sacrifice; we win.’”

The fund expects to invest in about 15 early-stage startups over a five-year span. Baylor declined to divulge the amount of money in the fund and the size of the investment in Nemea.

Nemea’s “world-class chemistry”

Hanson oversees the Baylor fund alongside Chicago investor Steve Lehmann, who led the University of Chicago’s Innovation Fund.

Lehmann said Nemea, the fund’s first portfolio company, “has world-class chemistry, Baylor biology, and patients with no good options. Our job is to fund the experiments that carry it to the next handoff, so that industry and later-stage investors can take it from there.”

Based at Houston’s massive Texas Medical Center, Nemea plans to start clinical trials next year in collaboration with Baylor’s Lester and Sue Smith Breast Center.

Nemea previously received $9 million from the Lead Discovery Center and a $1.6 million grant from Baylor. Last year, the startup said it was seeking $25 million to $30 million in seed and Series A funding.

Debra McCoy of Houston, a former managing director at BlackRock and former partner at Bain & Co., and Paul Thomas, co-founder and CEO of Spring-based benefits manager Luscinia Health, sit on the Baylor fund’s governing board. Dr. Paul Klotman, former president, CEO and executive dean of Baylor, is a senior strategic adviser.

How does the fund find investment targets?

The Baylor Legacy Fund relies on two tools to help unearth early-stage biotech startups:

  • High-resolution “innovation maps” of research institutions. These maps surface hidden clusters of innovation, identify rising-star researchers and tie pockets of “innovation supply” at Baylor to areas of “innovation demand” in biotech.
  • AI-enhanced due diligence. AI agents assist with due diligence of early-stage biotech startups. The fund says the platform “distills the frameworks we’ve developed over a decade of teaching and investing into a flexible … diligence environment.”

MD Anderson unveils $3.4B expansion with two new Houston cancer care facilities

major expansion

The cutting edge of cancer-fighting technology and science is getting even sharper after MD Anderson announced last week that it will open two new facilities in the Texas Medical Center within the next five years. Inspiration Tower and Prism will expand MD Anderson’s annual patient load in the TMC to 250,000 annually and will incorporate a variety of new techniques.

The $3.4 billion project will add 2 million square feet to MD Anderson's TMC footprint, bringing its total campus size to 22 million square feet by 2032. Located at the corner of Fannin Street and Holcombe Boulevard, the cancer center says the two new facilities will serve as its new "front door" to the TMC.

“Every detail of these buildings, from the technology to the treatment rooms, was designed around our patients who will receive their care in them and our employees who will work in them. The facilities will serve as a physical representation of hope for the patients and their families who will walk through the doors,” Dr. Jeffrey E. Lee, president ad interim of UT MD Anderson, said in a news release. “Inspiration Tower and Prism are the future of cancer care, and we are grateful for the longstanding support and guidance we’ve received from the UT System Board of Regents to bring these projects to life. These facilities are part of the most impactful capital expansion in UT MD Anderson’s history.”

Prism is especially exciting as it will represent fully half of the linear accelerator treatment in the TMC. Linear accelerator is a radiation treatment that uses magnetically charged fields to deliver targeted external radiation therapy, like shooting cancer with a rail gun. The treatment is safer and has fewer side effects than older radiation treatments.

In addition, Prism will contain 12 MRI machines, four CT scanners, two PET-CT units, 18 radiation vaults and seven radiation simulators. Patient comfort has also been put at a premium with multiple gardens and roof overlooks.

“Every patient we treat deserves an environment that reflects the excellence of the care they receive at UT MD Anderson,” Chris McKee, executive vice president and chief strategy officer at UT MD Anderson, added in the release. “Our new facilities will be innovative, agile, adaptable and beautiful, and they will allow us to care for more patients, more effectively – in an environment that enhances healing and well-being. We are building for our future and for every patient who will be counting on us.”

Prism is slated to open in 2030.

Inspiration Tower will have 25 floors of surgical, diagnostic, and treatment services. At 1.4 million square feet, it’s currently expected to be the largest cancer-specific treatment facility in the United States. The tower will be divided into units for specific types of cancer, making it easy to integrate the advancing research being done all over Houston.

Like Prism, Inspiration Tower is specifically designed to offer comfort and reassurance, with more garden space, terraces, and beautiful scenery to ease patient distress. It is expected to open in 2032.

Tesla will pull the plug on Cybertruck production at Texas factory in 2027

Tesla Talk

Tesla’s Cybertruck, the hulking, stainless-steel pickup that inspired devotion and derision with its science-fiction looks, will cease production next year.

CEO Elon Musk announced the model’s demise Friday, November 6, with a curt post on X, his social media site, simply noting production of the vehicle “will be winding down” around the middle of 2027 at its facility outside Austin, Texas. Musk said the move was to allow increased production of its Cybercab robotaxi.

For the Cybertruck, a pet project of Musk who insisted it was Tesla’s best product, it marks an unceremonious end to one of the auto industry’s most ballyhooed debuts.

“Few vehicles in history have generated as much attention,” said Armen Hareyan, whose Torque News site covers autos. “The Cybertruck became a cultural symbol – loved, mocked and impossible to ignore.”

The Cybertruck rolled onto the scene in a dramatic unveiling in 2019, when a Tesla designer hurled a metal ball at the vehicle to demonstrate its supposedly unbreakable glass, only to see it shatter. He repeated the stunt on another window of the truck only to shatter that one, too.

Even as some critics scoffed, Musk was steadfast.

“I just wanted to make a futuristic battle tank — something that looks like it could come out of ‘Blade Runner’ or ‘Aliens’ or something like that but was also highly functional,” he told Automotive News. He called it “a better sports car than a Porsche 911” and “a better truck than an F-150.”

It struck some as the perfect vehicular reflection of the brash, convention-busting Musk.

“A really controversial vehicle unveiled by a controversial individual into a market where none of the electric trucks have been able to really capture demand,” said Spencer Penn, a former Tesla executive who left the company before the Cybertruck’s launch and now heads software developer LightSource.

Penn remembered watching the unveiling and feeling initially revolted by the sight of the Cybertruck, calling its appearance “madness.” But the more he looked at it, the more his opinion changed. He signed up for a pre-sale reservation, though ended up not getting a Cybertruck when Musk’s promises of a price tag under $40,000 went unmet and the first trucks sold for double or more. Penn called the Cybertruck part of Tesla’s adventurous spirit that drives innovation.

“Some of these bets work and some of these bets don’t,” he said.

While the decision to end Cybertruck production may be driven by sales realities, it's also a reflection of Tesla’s shift to autonomous vehicles, on which Musk is betting the company’s future.

Musk once forecast he’d make 250,000 Cybertrucks a year. Kelley Blue Book estimated Tesla sold just 20,237 of the vehicles last year, down about half from the year prior. Sales through the end of September this year were down another 28%, according to Kelley Blue Book.

If the imposing, sharp-angled, dystopian appearance of the Cybertruck weren’t enough to turn many potential buyers away, Musk did so himself by allying with a panoply of right-wing figures, most notably U.S. President Donald Trump. He alienated some customers as his image morphed from eccentric innovator to polarizing force trading his billions for political influence.

Once-passionate Tesla drivers rushed to sell off their cars, or slapped stickers on the bumper declaring, “I bought this before Elon went crazy.” Organizers staged demonstrations outside Tesla showrooms and urged investors to dump shares of the company’s stock. Anger spilled into violence, with Molotov cocktails hurled at Tesla vehicles, charging stations set ablaze, and dealerships covered in graffiti.

Lovers of the Cybertruck became targets, too, subjected to shouts of “Nazi!” and extended middle fingers.

Ross Blankenship is one of them. When he first laid eyes on the Cybertruck, he felt transported to a world from his childhood, when he would play “Halo,” the sci-fi video game. He had to have it.

“I had that sort of child in me wanting to be part of something cool that would change the future of automotive,” Blankenship said in a call from his Cybertruck as he drove through Sunnyside, Colorado. Even as Blankenship found he agreed with Musk on politics, he hated seeing a vehicle he loved turned into a political symbol. “I never bought it for any other reason than the fascination with the future technology of trucks … so that was a little heartbreaking.”

He would buy another Cybertruck again in a heartbeat, calling its end “a sad moment.”